CD44 deficiency is associated with increased bacterial clearance but enhanced lung inflammation during gram-negative pneumonia

American Journal of Pathology

Volumn 177, Issue 5, 2010, Pages 2483-2494

  Van Der Windt, Gerritje J W ^a   Florquin, Sandrine ^a   De Vos, Alex F ^a   Van't Veer, Cornelis ^a   Queiroz, Karla C S ^a   Liang, Jiurong ^b   Jiang, Dianhua ^b   Noble, Paul W ^b   Van Der Poll, Tom ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; HERMES ANTIGEN; HYALURONIC ACID; INTERLEUKIN 1 RECEPTOR; TOLL LIKE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL PNEUMONIA; BACTERIAL STRAIN; COLONY FORMING UNIT; CONTROLLED STUDY; GENE EXPRESSION; GRAM NEGATIVE BACTERIUM; HISTOPATHOLOGY; KLEBSIELLA PNEUMONIAE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 78149332761     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.100562     Document Type: Article

References (46)

1. Burwen DR, Banerjee SN, Gaynes RP: Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States: National Nosocomial Infections Surveillance System. J Infect Dis 1994, 170:1622-1625
2. Podschun R, Ullmann U: Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 1998, 11:589-603
3. Yinnon AM, Butnaru A, Raveh D, Jerassy Z, Rudensky B: Klebsiella bacteraemia: community versus nosocomial infection. QJM 1996, 89:933-941
4. Wheeler AP, Bernard GR: Treating patients with severe sepsis. N Engl J Med 1999, 340:207-214
5. Culty M, Nguyen HA, Underhill CB: The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J Cell Biol 1992, 116:1055-1062
6. Isacke CM, Yarwood H: The hyaluronan receptor. CD44 Int J Biochem Cell Biol 2002, 34:718-721
7. Pure E, Cuff CA: A crucial role for CD44 in inflammation. Trends Mol Med 2001, 7:213-221
8. Liang J, Jiang D, Griffith J, Yu S, Fan J, Zhao X, Bucala R, Noble PW: CD44 is a negative regulator of acute pulmonary inflammation and lipopolysaccharide-TLR signaling in mouse macrophages. J Immunol 2007, 178:2469-2475
9. Wang Q, Teder P, Judd NP, Noble PW, Doerschuk CM: CD44 deficiency leads to enhanced neutrophil migration and lung injury in Escherichia coli pneumonia in mice. Am J Pathol 2002, 161:2219-2228
10. Rouschop KM, Roelofs JJ, Claessen N, da Costa Martins P, Zwaginga JJ, Pals ST, Weening JJ, Florquin S: Protection against renal ischemia reperfusion injury by CD44 disruption. J Am Soc Nephrol 2005, 16:2034-2043
11. Rouschop KM, Sylva M, Teske GJ, Hoedemaeker I, Pals ST, Weening JJ, van der Poll T, Florquin S: Urothelial CD44 facilitates Escherichia coli infection of the murine urinary tract. J Immunol 2006, 177:7225-7232
12. Teder P, Vandivier RW, Jiang D, Liang J, Cohn L, Pure E, Henson PM, Noble PW: Resolution of lung inflammation by CD44. Science 2002, 296:155-158
13. Moffat FL Jr, Han T, Li ZM, Peck MD, Falk RE, Spalding PB, Jy W, Ahn YS, Chu AJ, Bourguignon LY: Involvement of CD44 and the cytoskeletal linker protein ankyrin in human neutrophil bacterial phagocytosis. J Cell Physiol 1996, 168:638-647
14. Leemans JC, Florquin S, Heikens M, Pals ST, van der Neut R, Van Der Poll T: CD44 is a macrophage binding site for Mycobacterium tuberculosis that mediates macrophage recruitment and protective immunity against tuberculosis. J Clin Invest 2003, 111:681-689
15. Schmits R, Filmus J, Gerwin N, Senaldi G, Kiefer F, Kundig T, Wakeham A, Shahinian A, Catzavelos C, Rak J, Furlonger C, Zakarian A, Simard JJ, Ohashi PS, Paige CJ, Gutierrez-Ramos JC, Mak TW: CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood 1997, 90:2217-2233
16. Renckens R, Roelofs JJ, Bonta PI, Florquin S, de Vries CJ, Levi M, Carmeliet P, van't Veer C, van der Poll T: Plasminogen activator inhibitor type 1 is protective during severe Gram-negative pneumonia. Blood 2007, 109:1593-1601
17. Rijneveld AW, Weijer S, Florquin S, Esmon CT, Meijers JC, Speelman P, Reitsma PH, Ten Cate H, van der Poll T: Thrombomodulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharide. Blood 2004, 103:1702-1709
18. Renckens R, Roelofs JJ, Stegenga ME, Florquin S, Levi M, Carmeliet P, Van't Veer C, van der Poll T: Transgenic tissue-type plasminogen activator expression improves host defense during Klebsiella pneumonia. J Thromb Haemost 2008, 6:660-668
19. Dessing MC, Knapp S, Florquin S, de Vos AF, van der Poll T: CD14 facilitates invasive respiratory tract infection by Streptococcus pneumoniae. Am J Respir Crit Care Med 2007, 175:604-611
20. Garantziotis S, Li Z, Potts EN, Kimata K, Zhuo L, Morgan DL, Savani RC, Noble PW, Foster WM, Schwartz DA, Hollingsworth JW: Hyaluronan mediates ozone-induced airway hyperresponsiveness in mice. J Biol Chem 2009, 284:11309-11317
21. Savani RC, Hou G, Liu P, Wang C, Simons E, Grimm PC, Stern R, Greenberg AH, DeLisser HM, Khalil N: A role for hyaluronan in macrophage accumulation and collagen deposition after bleomycin-induced lung injury. Am J Respir Cell Mol Biol 2000, 23:475-484
22. Knapp S, Wieland CW, Florquin S, Pantophlet R, Dijkshoorn L, Tshimbalanga N, Akira S, van der Poll T: Differential roles of CD14 and toll-like receptors 4 and 2 in murine Acinetobacter pneumonia. Am J Respir Crit Care Med 2006, 173:122-129
23. Rijneveld AW, Levi M, Florquin S, Speelman P, Carmeliet P, van Der Poll T: Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia. J Immunol 2002, 168:3507-3511
24. Lupberger J, Kreuzer KA, Baskaynak G, Peters UR, le Coutre P, Schmidt CA: Quantitative analysis of beta-actin, beta-2-microglobulin and porphobilinogen deaminase mRNA and their comparison as control transcripts for RT-PCR. Mol Cell Probes 2002, 16:25-30
25. del Fresno C, Otero K, Gomez-Garcia L, Gonzalez-Leon MC, Soler-Ranger L, Fuentes-Prior P, Escoll P, Baos R, Caveda L, Garcia F, Arnalich F, Lopez-Collazo E: Tumor cells deactivate human monocytes by up-regulating IL-1 receptor associated kinase-M expression via CD44 and TLR4. J Immunol 2005, 174:3032-3040
26. McKee CM, Penno MB, Cowman M, Burdick MD, Strieter RM, Bao C, Noble PW: Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages: the role of HA size and CD44 J Clin Invest 1996, 98:2403-2413
27. Jiang D, Liang J, Fan J, Yu S, Chen S, Luo Y, Prestwich GD, Mascarenhas MM, Garg HG, Quinn DA, Homer RJ, Goldstein DR, Bucala R, Lee PJ, Medzhitov R, Noble PW: Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 2005, 11:1173-1179
28. Garantziotis S, Li Z, Potts EN, Lindsey JY, Stober VP, Polosukhin VV, Blackwell TS, Schwartz DA, Foster WM, Hollingsworth JW: TLR4 is necessary for hyaluronan-mediated airway hyperresponsiveness after ozone inhalation. Am J Respir Crit Care Med 2010, 181:666-675
29. Mizgerd JP: Acute lower respiratory tract infection. N Engl J Med 2008, 358:716-727
30. Strieter RM, Belperio JA, Keane MP: Cytokines in innate host defense in the lung. J Clin Invest 2002, 109:699-705
31. Si-Tahar M, Sitaraman S, Shibahara T, Madara JL: Negative regulation of epithelium-neutrophil interactions via activation of CD44. Am J Physiol Cell Physiol 2001, 280:C423-C432
32. Fillion I, Ouellet N, Simard M, Bergeron Y, Sato S, Bergeron MG: Role of chemokines and formyl peptides in pneumococcal pneumonia-induced monocyte/macrophage recruitment. J Immunol 2001, 166:7353-7361
33. Hollingsworth JW, Li Z, Brass DM, Garantziotis S, Timberlake SH, Kim A, Hossain I, Savani RC, Schwartz DA: CD44 regulates macrophage recruitment to the lung in lipopolysaccharide-induced airway disease. Am J Respir Cell Mol Biol 2007, 37:248-253
34. Gonda A, Gal I, Szanto S, Sarraj B, Glant TT, Hunyadi J, Mikecz K: CD44, but not l-selectin, is critically involved in leucocyte migration into the skin in a murine model of allergic dermatitis. Exp Dermatol 2005, 14:700-708
35. McDonald B, McAvoy EF, Lam F, Gill V, de la Motte C, Savani RC, Kubes P: Interaction of CD44 and hyaluronan is the dominant mechanism for neutrophil sequestration in inflamed liver sinusoids. J Exp Med 2008, 205:915-927
36. Kimura K, Nagaki M, Kakimi K, Saio M, Saeki T, Okuda Y, Kuwata K, Moriwaki H: Critical role of CD44 in hepatotoxin-mediated liver injury. J Hepatol 2008, 48:952-961
37. DeGrendele HC, Estess P, Picker LJ, Siegelman MH: CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte- endothelial cell primary adhesion pathway. J Exp Med 1996, 183:1119-1130
38. DeGrendele HC, Estess P, Siegelman MH: Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 1997, 278:672-675
39. van der Windt GJ, van 't Veer C, Florquin S, van der Poll T: CD44 deficiency is associated with enhanced Escherichia coli-induced proinflammatory cytokine and chemokine release by peritoneal macrophages. Infect Immun 2010, 78:115-124
40. Harada H, Takahashi M: CD44-dependent intracellular and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and -2. J Biol Chem 2007, 282:5597-5607
41. Noble PW, McKee CM, Cowman M, Shin HS: Hyaluronan fragments activate an NF-kappa B/I-kappa B alpha autoregulatory loop in murine macrophages. J Exp Med 1996, 183:2373-2378
42. Voelcker V, Gebhardt C, Averbeck M, Saalbach A, Wolf V, Weih F, Sleeman J, Anderegg U, Simon J: Hyaluronan fragments induce cytokine and metalloprotease upregulation in human melanoma cells in part by signalling via TLR4. Exp Dermatol 2008, 17:100-107
43. Taylor KR, Trowbridge JM, Rudisill JA, Termeer CC, Simon JC, Gallo RL: Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem 2004, 279:17079-17084
44. Scheibner KA, Lutz MA, Boodoo S, Fenton MJ, Powell JD, Horton MR: Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol 2006, 177:1272-1281
45. Savani RC, Khalil N, Turley EA: Hyaluronan receptor antagonists alter skin inflammation and fibrosis following injury. Proc West Pharmacol Soc 1995, 38:131-136
46. Mummert ME, Mohamadzadeh M, Mummert DI, Mizumoto N, Takashima A: Development of a peptide inhibitor of hyaluronan-mediated leukocyte trafficking. J Exp Med 2000, 192:769-779